Constipation-type irritable bowel syndrome
Conditions
Interventions
Placebo control group:Placebo granules
Yunpi Rougan formula Group:Take Yun Spleen Rougan Fang Granules
Sponsors
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of IBS-C in traditional Chinese and Western medicine; (2) Age 18~80 years old, gender is not limited; (3) Informed consent, voluntary participation in the study.
Exclusion criteria
Exclusion criteria: (1) Those with organic lesions of the gastrointestinal tract; (2) Those with serious heart, liver, kidney, respiratory, blood and endocrine diseases; (3) Psychiatric patients and patients with severe neurosis; (4) pregnant or lactating women; (5) Those who have poor compliance with doctor's instructions and are allergic to this drug; (6) Patients who have participated in other drug clinical studies in the past 3 months or are participating in other drug clinical studies; (7) Alcoholic and drug abusers and drug abusers*; (8) Those who have taken antibiotics or probiotic preparations or gastrointestinal prokinetic drugs within 1 month before the inclusion trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall clinical efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| IBS-quality of life (IBS-QOL);TCM Syndrome Points;Assessment of mental status;IBS symptom severity score IBS-SSS; | — |
Countries
China
Contacts
Public ContactGu Chao
Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Outcome results
None listed